EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
2.140
-0.030 (-1.38%)
At close: Oct 31, 2025, 4:00 PM EDT
2.060
-0.080 (-3.74%)
After-hours: Oct 31, 2025, 5:07 PM EDT
EDAP TMS Revenue
EDAP TMS had revenue of 16.04M EUR in the quarter ending June 30, 2025, with 1.60% growth. This brings the company's revenue in the last twelve months to 63.02M, up 1.56% year-over-year. In the year 2024, EDAP TMS had annual revenue of 64.12M with 6.11% growth.
Revenue (ttm)
63.02M EUR
Revenue Growth
+1.56%
P/S Ratio
1.08
Revenue / Employee
203,284 EUR
Employees
310
Market Cap
80.02M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.12M | 3.69M | 6.11% |
| Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
| Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
| Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
| Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
EDAP News
- 6 days ago - EDAP to Participate in the UBS Global Healthcare Conference - GlobeNewsWire
- 10 days ago - EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 13 days ago - EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU - GlobeNewsWire
- 4 weeks ago - Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option - GlobeNewsWire
- 6 weeks ago - Focal One® HIFU Receives Prestigious Innovation Award - GlobeNewsWire
- 7 weeks ago - EDAP Receives HIFU Reimbursement for Prostate Cancer in France - GlobeNewsWire
- 2 months ago - EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - EDAP Reports Strong Second Quarter 2025 HIFU Results - GlobeNewsWire